- cafead Apr 23, 2021 at 11:32: AM
via U.S. officials have pulled the plug on funding a phase 3 trial for Inovio’s COVID-19 vaccine, telling the biotech that another vaccine is no longer needed as inoculations pick up around the country.
The Plymouth Meeting, Pa.-based biotech’s shares tumbled around 28% on the news as the market opened, dropping to $6.60 from $9.13 the day before.
article source
The Plymouth Meeting, Pa.-based biotech’s shares tumbled around 28% on the news as the market opened, dropping to $6.60 from $9.13 the day before.
article source